Abbonarsi

Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures: a systematic review - 01/06/16

Doi : 10.1016/j.gie.2015.04.030 
Udayakumar Navaneethan, MD 1, , Muhammad K. Hasan, MD 1, Vennisvasanth Lourdusamy, MD 1, Basile Njei, MD, MPH 2, Shyam Varadarajulu, MD 1, Robert H. Hawes, MD 1
1 Center for Interventional Endoscopy, Institute for Minimally Invasive Surgery, Florida Hospital, Orlando, Florida, USA 
2 Department of Gastroenterology, Yale University, New Haven, Connecticut, USA 

Reprint requests: Udayakumar Navaneethan, MD, FACP, Center for Interventional Endoscopy, Institute for Minimally Invasive Surgery, Florida Hospital, 601 E Rollins Street, Orlando, FL 32814.

Abstract

Background and Aims

Evaluation of indeterminate biliary strictures by brush cytology and intraductal biopsies is limited by low sensitivity. The utility of SpyGlass peroral cholangioscopy for diagnosis of malignant biliary strictures and cholangiocarcinoma (CCA), in particular, remains unclear. Our aim was to study the utility of SpyGlass peroral cholangioscopy and targeted biopsy for diagnosis of malignant biliary strictures and CCA.

Methods

In this systematic review, PubMed and Embase databases were reviewed for studies published to October 2014. The main outcomes of interest were sensitivity, specificity, and diagnostic odds ratio (DOR) of SpyGlass cholangioscopy in the diagnosis of malignant biliary strictures.

Results

The search yielded 10 studies involving 456 patients. The pooled sensitivity and specificity of cholangioscopy-guided biopsies in the diagnosis of malignant biliary strictures was 60.1% (95% confidence interval [CI], 54.9%-65.2%) and 98.0% (95% CI, 96.0%-99.0%), respectively. The pooled DOR to detect malignant biliary strictures was 66.4 (95% CI, 32.1-137.5). Four studies included patients who had previous negative imaging and brushings and/or intraductal biopsies. Among these 4 studies, the pooled sensitivity and specificity for diagnosis of malignant biliary strictures was 74.7% (95% CI, 63.3%-84.0%) and 93.3% (95% CI, 85.1%-97.8%), respectively. The pooled DOR was 46.0 (95% CI, 15.4-138.1). Only 1 study directly compared the yield of SpyBite biopsies with standard brushings and biopsies. SpyBite biopsies had a sensitivity of 76.5% compared with brushings (5.8%) and biopsies (29.4%). Six studies specifically reported the role of cholangioscopy with targeted biopsies in the diagnosis of CCA. The pooled sensitivity and specificity to detect CCA was 66.2% (95% CI, 59.7%-72.3%) and 97.0% (95% CI, 94.0%-99.0%), respectively. The pooled DOR to detect CCA was 79.7 (95% CI, 32.7-194.7).

Conclusions

Our study suggests that SpyGlass cholangioscopy with SpyBite biopsies has moderate sensitivity for the diagnosis of malignant biliary strictures.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : CCA, DOR, FISH, LR, POC, QUADAS, SOPOC


Mappa


 DISCLOSURE: U. Navaneethan is a consultant for AbbVie. R. Hawes and S. Varadarajulu are consultants for Olympus and Boston Scientific. All other authors disclosed no financial relationships relevant to this publication.
 If you would like to chat with an author of this article, you may contact Dr Navaneethan at udhaykumar81@gmail.com.


© 2015  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 82 - N° 4

P. 608 - ottobre 2015 Ritorno al numero
Articolo precedente Articolo precedente
  • The role of deep enteroscopy in the management of small-bowel disorders
  • ASGE Standards of Practice Committee, Mouen A. Khashab, Shabana F. Pasha, V. Raman Muthusamy, Ruben D. Acosta, David H. Bruining, Vinay Chandrasekhara, Krishnavel V. Chathadi, Mohamad A. Eloubeidi, Robert D. Fanelli, Ashley L. Faulx, Lisa Fonkalsrud, Suryakanth R. Gurudu, Loralee R. Kelsey, Shivangi Kothari, Jenifer R. Lightdale, John R. Saltzman, Aasma Shaukat, Amy Wang, Julie Yang, Brooks D. Cash, John M. DeWitt
| Articolo seguente Articolo seguente
  • Single-operator cholangioscopes in the diagnosis of cholangiocarcinoma: seeing is believing. Is belief enough to allow treatment?
  • Richard A. Kozarek

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.